Srinivas Akkaraju
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 5 boards, counting each seat separately. Longest: Mineralys Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Mineralys Therapeutics Inc. May 21, 202660.6%
-
Kalaris Therapeutics Inc. August 12, 202599.0%
-
Alumis Inc. July 30, 202587.7%
-
vTv Therapeutics Inc. June 10, 202594.7%
-
vTv Therapeutics Inc. June 11, 202499.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 26, 2026 | Scholar Rock Holding Corporation | Open-market purchase | +48,988 | $41.59 | $2,037,411 |
| Oct 26, 2026 | Scholar Rock Holding Corporation | Open-market purchase | +97,982 | $41.59 | $4,075,071 |
| Oct 23, 2026 | Scholar Rock Holding Corporation | Open-market purchase | +47,000 | $41.31 | $1,941,570 |
| Oct 23, 2026 | Scholar Rock Holding Corporation | Open-market purchase | +94,000 | $41.31 | $3,883,140 |
| Oct 23, 2026 | Scholar Rock Holding Corporation | Open-market purchase | +500 | $41.82 | $20,910 |
| Oct 23, 2026 | Scholar Rock Holding Corporation | Open-market purchase | +1,000 | $41.82 | $41,820 |
| Sep 8, 2026 | Alumis Inc. | Open-market sale | −48,066 | $10.55 | $507,096 |
| Sep 8, 2026 | Alumis Inc. | Open-market sale | −48,065 | $10.55 | $507,086 |
| Sep 8, 2026 | Alumis Inc. | Open-market purchase | +273,291 | $10.63 | $2,905,083 |
| Sep 8, 2026 | Alumis Inc. | Open-market purchase | +273,290 | $10.63 | $2,905,073 |
| Sep 4, 2026 | Alumis Inc. | Open-market purchase | +220,070 | $11.17 | $2,458,182 |
| Sep 4, 2026 | Alumis Inc. | Open-market purchase | +220,070 | $11.17 | $2,458,182 |
| Jun 30, 2026 | Alumis Inc. | Grant or award | +3,553 | — | — |
| Jun 4, 2026 | Scholar Rock Holding Corporation | Grant or award | +6,839 | — | — |
| May 20, 2026 | Kalaris Therapeutics Inc. | Open-market purchase | +244,300 | $4.83 | $1,179,969 |
Questions about Srinivas Akkaraju
What boards is Srinivas Akkaraju on?
Srinivas Akkaraju sits on the boards of Alumis Inc., Kalaris Therapeutics Inc., Mineralys Therapeutics Inc., Scholar Rock Holding Corporation and vTv Therapeutics Inc.
How long has Srinivas Akkaraju served on boards?
Our records show at least 14 years of board service across 5 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.